0000950170-24-073281.txt : 20240613
0000950170-24-073281.hdr.sgml : 20240613
20240613211836
ACCESSION NUMBER: 0000950170-24-073281
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240503
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zovighian Bernard J
CENTRAL INDEX KEY: 0001665141
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 241042851
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4/A
1
ownership.xml
4/A
X0508
4/A
2024-05-03
2024-05-07
0001099800
Edwards Lifesciences Corp
EW
0001665141
Zovighian Bernard J
ONE EDWARDS WAY
IRVINE
CA
92614
true
true
false
false
CEO
false
Common Stock
3267.6552
I
401(k)
Total reflects an acquisition of 580.2601 shares of the Issuer's Common Stock on May 6, 2024 under the Issuer's 401(k) Plan in a transaction exempted by Rule 16b-3, as well as 2,558 shares held under the Issuer's 401(k) Plan that were previously reported as directly held.
This amendment to the Form 4 filed on May 7, 2024 by the Reporting Person is filed to remove the reporting of the acquisition of shares described in Footnote 1, as it was an exempt transaction in the Issuer's Common Stock pursuant to Section 16b-3(c) of the Securities Exchange Act of 1934, as amended, and to disclose the number of shares beneficially owned indirectly by the Reporting Person as represented on the most recent statement of the Issuer's 401(k) Plan Administrator.
/s/ Linda J. Park, Attorney-in-Fact
2024-06-13